Inovio Pharmaceuticals Cash Flow Statement Analysis

Operating, investing, and financing activities in millions USD

Scroll to see more
Cash flow statement showing operating, investing, and financing activities for Inovio Pharmaceuticals, Inc. (INO) - Annual data in millions USD
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018
Operating Activities
Net Income-107.25-135.12-279.82-303.66-167.47-120.55-96.97
Depreciation & Amortization3.133.505.504.734.635.525.00
Deferred Income Tax0.00-0.030.000.000.000.000.00
Stock Based Compensation6.6011.0722.5626.3415.650.000.00
Change in Working Capital-2.66-10.2619.8355.28-4.40-1.204.71
Change in Accounts Receivable1.219.33-3.7111.03-17.020.000.00
Change in Accounts Payable-3.37-45.9932.6126.143.250.000.00
Change in Other Working Capital-0.3928.850.1916.19-57.870.000.00
Other Operating Activities-3.160.120.1926.05-15.3718.390.00
Net Cash from Operating Activities-104.08-124.37-216.22-215.71-177.98-97.85-73.55
Investing Activities
Capital Expenditures-0.49-0.32-0.971.231.520.99-2.09
Acquisitions0.000.00-2.000.00-4.170.000.00
Purchases of Investments104.5081.46-248.53-174.11-54.500.000.00
Sales/Maturities of Investments158.64-203.48361.08-174.11-53.10-8.0644.50
Other Investing Activities-0.430.000.000.0040.130.000.00
Net Cash from Investing Activities104.0787.36109.59-175.34-58.80-9.0442.42
Financing Activities
Debt Repayment-16.420.000.000.000.00-3.310.00
Common Stock Issued36.105.4682.96209.44454.499.0929.23
Common Stock Repurchased-0.42-0.47-1.40-4.61-4.030.000.00
Other Financing Activities32.21-0.47-1.40-4.612.382.96-0.61
Net Cash from Financing Activities51.485.0081.84211.50465.28105.4031.04
Summary
Effect of Forex Changes on Cash0.030.00-0.03-0.030.030.470.00
Net Change in Cash51.50-32.02-24.79-179.55228.53-1.50-0.09
Cash at Beginning of Period14.3146.3371.14250.7322.2023.6923.79
Cash at End of Period65.81-327.9246.3371.14250.7322.2023.69
Free Cash Flow-104.56-124.69-217.18-216.94-179.50-98.84-75.64
Supplemental Disclosures
Interest Paid0.531.071.071.084.622.720.00